Skip to main content
Equibles

BARCLAYS PLC

Position in TCRX — TScan Therapeutics, Inc.

CIK 312069 LONDON, X0
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,786
+$1,536 QoQ
Shares Held
19,170
+12.2% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 60 holders
Holding Since
Mar 2022
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. TCRX ranks #311 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in TCRX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,786 19,170
2026-03-31 $17,250 17,080
2025-12-31 $23,196 23,196
2025-09-30 $34,719 19,077
2025-06-30 $30,708 21,178
2025-03-31 $85,353 61,850
2024-12-31 $205,224 67,508
2024-09-30 $289,173 58,067
2024-06-30 $77,009 13,164
2022-03-31 $445,043 158,944